Primary |
Asthma |
61.5% |
Product Used For Unknown Indication |
30.8% |
Bronchitis |
7.7% |
|
Asthma |
25.0% |
Inappropriate Schedule Of Drug Administration |
25.0% |
Meniscus Injury |
12.5% |
Pyrexia |
12.5% |
Swelling |
12.5% |
Wheezing |
12.5% |
|
Secondary |
Asthma |
28.9% |
Chronic Obstructive Pulmonary Disease |
21.1% |
Product Used For Unknown Indication |
15.8% |
Sinusitis |
15.8% |
Hypertension |
7.9% |
Bronchitis |
2.6% |
Drug Use For Unknown Indication |
2.6% |
Gastrooesophageal Reflux Disease |
2.6% |
Thyroid Disorder |
2.6% |
|
Product Quality Issue |
22.2% |
Drug Ineffective |
11.1% |
General Physical Health Deterioration |
11.1% |
Meniscus Injury |
11.1% |
Mood Swings |
11.1% |
Oral Mucosal Eruption |
11.1% |
Pneumonia |
11.1% |
Pruritus |
11.1% |
|
Concomitant |
Product Used For Unknown Indication |
33.3% |
Asthma |
18.6% |
Chronic Obstructive Pulmonary Disease |
9.6% |
Hypertension |
6.2% |
Gastrooesophageal Reflux Disease |
3.4% |
Rheumatoid Arthritis |
3.0% |
Hypersensitivity |
2.5% |
Osteoporosis |
2.5% |
Nausea |
2.4% |
Blood Cholesterol Increased |
2.3% |
Constipation |
1.9% |
Atrial Fibrillation |
1.8% |
Contraception |
1.8% |
Depression |
1.8% |
Prophylaxis |
1.7% |
Diabetes Mellitus |
1.6% |
Hypothyroidism |
1.6% |
Pain |
1.6% |
Hereditary Angioedema |
1.3% |
Abdominal Pain Upper |
1.2% |
|
Pulmonary Embolism |
11.9% |
Throat Tightness |
11.9% |
Weight Increased |
7.1% |
Pyrexia |
6.0% |
Vomiting |
6.0% |
Wheezing |
6.0% |
Product Quality Issue |
4.8% |
Visual Impairment |
4.8% |
Chronic Obstructive Pulmonary Disease |
3.6% |
Pain |
3.6% |
Postoperative Wound Infection |
3.6% |
Rhinorrhoea |
3.6% |
Sinusitis |
3.6% |
Swelling |
3.6% |
Thrombophlebitis Superficial |
3.6% |
Thrombosis |
3.6% |
Uterine Leiomyoma |
3.6% |
Vision Blurred |
3.6% |
Weight Decreased |
3.6% |
Cough |
2.4% |
|